GeoVax Labs (GOVX) jumps 178% as traders refocus on mpox vaccine thesis after recent Q1 update

GeoVax Labs (GOVX) is up 178.0% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears driven more by high-volatility microcap trading dynamics than by a brand-new announcement, with attention returning to GeoVax’s GEO-MVA mpox/smallpox vaccine program following its recent quarterly business update. Momentum buying may have been amplified by the company’s low market capitalization and the market’s tendency to re-rate vaccine-focused names on renewed “Phase 3 in 2026” framing. This could also be partly a squeeze-style move as liquidity shifts quickly in thinly traded stocks.

Details:

GeoVax released a quarterly update that reiterated GEO-MVA as its priority program and discussed plans to initiate a pivotal Phase 3 immuno-bridging study during the second half of 2026.

Recent SEC filings highlighted a tight cash position and management’s view that existing cash was expected to fund operations only into June 2026, increasing the stock’s sensitivity to any perceived positive catalyst or financing narrative.

GeoVax previously emphasized GEO-MVA as a potential second-source MVA vaccine aimed at addressing global mpox/smallpox vaccine supply constraints, a theme that can attract speculative interest during outbreak- and preparedness-related headlines.

The company has used warrant exercises/inducements and other equity-linked financing tools in 2026, which can change float dynamics and contribute to sharp, news-adjacent price swings.

Sources:

SEC, GeoVax Labs Investor Relations, Zacks

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

EARLY ACCESS

Receive GOVX Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$GOVX Hedge Fund Activity

We have seen 11 institutional investors add shares of $GOVX stock to their portfolio, and 19 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

SABBY MANAGEMENT, LLC removed 661,376 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $113,095
ARMISTICE CAPITAL, LLC added 269,253 shares (+inf%) to their portfolio in Q1 2026, for an estimated $371,569
VANGUARD GROUP INC removed 234,396 shares (-96.0%) from their portfolio in Q4 2025, for an estimated $40,081
HUDSON BAY CAPITAL MANAGEMENT LP removed 100,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $17,100
GEODE CAPITAL MANAGEMENT, LLC added 27,793 shares (+335.5%) to their portfolio in Q1 2026, for an estimated $38,354
CITADEL ADVISORS LLC removed 24,615 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $33,968
RENAISSANCE TECHNOLOGIES LLC removed 24,261 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $33,480

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.